Business
Cipher Pharmaceuticals Schedules Q2 2020 Earnings Release and Conference Call
Cipher Pharmaceuticals Schedules Q2 2020 Earnings Release and Conference Call Cana...
About this update from Cipher Pharmaceuticals Inc.
[{"type":"text","content":"\n\n\n\nCipher Pharmaceuticals Schedules Q2 2020 Earnings Release and Conference Call\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\n\nCanada NewsWire\nOAKVILLE, ON, July 27, 2020\n\n\n\n OAKVILLE, ON, July 27, 2020 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (\"Cipher\" or \"the Company\") today announced it will release its Q2 2020 financial results after the close on Wednesday, August 12, 2020.  The Company will hold a conference call on Thursday, August 13, 2020 to discuss the results.  \nCONFERENCE CALL DETAILS\nDATE: Thursday, August 13, 2020 TIME: 8:30 a.m ET DIAL-IN: (416) 764-8688 or (888) 390-0546 CONFERENCE ID:      37039570 REPLAY DIAL-IN:     1 (888) 390-0541 (Playback 039570#) Expires August 20, 2020 Webcast: https://produceredition.webcasts.com/starthere.jsp?ei=1349740&tp_key=fe3acf5205\nAbout Cipher Pharmaceuticals Inc. Cipher Pharmaceuticals (TSX: CPH) is a specialty pharmaceutical company with a robust and diversified portfolio of commercial and early to late-stage products. Cipher acquires products that fulfill unmet medical needs, manages the required clinical development and regulatory approval process, and currently markets those products either directly in Canada or indirectly through partners in Canada, the U.S., and South America. For more information, visit www.cipherpharma.com.\nSOURCE Cipher Pharmaceuticals Inc.\n\n\n\n View original content: http://www.newswire.ca/en/releases/archive/July2020/27/c4388.html\n\n\n\n\nJames Bowen, CFA, Investor Relations - Cipher Pharmaceuticals, (416) 519-9442, [email protected] CNW Group 2020","length":3441,"tagName":"div"}]